Recent Coverage


December 19, 2014

VP Lee Buckler Podcast Interview by Midas Letter
Written By: James West Listen to the full interview here. RepliCel’s VP Lee Buckler explains the excitement among company stakeholders surrounding upcoming trials of... Read full article

December 2, 2014

Chronic Achilles Tendinosis Video Launched
Using Your Own Cells to Heal Tendon Injuries RepliCel is developing an autologous cell-based product for the treatment of chronic Achilles tendinosis.  This treatment... Read full article

November 7, 2014

November 7, 2014 – R. Lee Buckler: How RepliCel is Harnessing the Awesome Power of Cell Therapy
  To read the full report, click here: R. Lee Bucker on RepliCel Life Sciences Regenerative medicine and cell therapies hold possibilities for achieving... Read full article

October 24, 2014

Midas Letter Interviews CEO David Hall
To listen to the full interview podcast and read the transcript click here: Midas Letter Interviews David Hall Full Transcript: James West: Let’s start off... Read full article

October 22, 2014

Japan Gives a Hug to the Cell Therapy Industry: R. Lee Buckler
To read the full report click here: R. Lee Buckler on the Cell Therapy Industry Last year, Japan rolled out the red carpet for... Read full article

October 10, 2014

Seeking Alpha – Why RepliCel is a Promising Under-Researched Small-Cap Biotech
By: Eric Chiu, Biotech, Healthcare Contributor Published October 10, 2014 To read the entire article as it appears on Seeking Alpha click here. Summary... Read full article

September 25, 2014

Seeking Alpha Article – RepliCel Offers Significant Upside
To view the article as it appears on Seeking Alpha, click here. Summary RepliCel is a rare blend of upside potential and risk mitigation. The... Read full article

September 9, 2014

September 9th, 2014- Featured in the Financial Post: New Technology Puts Your Own Cells to Work to Repair and Rejuvenate Your Body
To read the full report click here: RepliCel’s Cutting-Edge Advancements The following has been published in the Financial Post: There is enormous interest in... Read full article

September 9, 2014

September 9th, 2014- RepliCel marches ahead with cell therapy trials
New in BioWorld, the latest in RepliCel’s cell therapy trials and what they could mean for improving Achilles tendinosis, aging and sun-damaged skin. Read full article

August 7, 2014

August 7, 2014 – Mark Landy from Summer Street Research Partners Comments on RepliCel in August’s issues of The Life Sciences Report
To read the full report click here: Mark Landy on New Growth Ideas for Biotech Investors The following is an excerpt from The Life... Read full article